Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $98.42M.
ENTERPRISE VALUE (EV)
$98.42M
InterCure Ltd.
Market Cap
$63.02M
Enterprise Value (EV)
$98.42M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| InterCure Ltd. (INCR) | $63.02M | $98.42M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | $67.02M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
| RenovoRx, Inc. (RNXT)vs › | $64.20M | $54.98M |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.35M | $191.99M |
| Gossamer Bio, Inc. (GOSS)vs › | $64.41M | $62.36M |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.20M | $19.43M |
| Cingulate Inc. (CING)vs › | $64.92M | $42.81M |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | N/A |
| XBiotech Inc. (XBIT)vs › | $66.07M | N/A |
Market Cap
$63.02M
Total Debt
$49.98M
Cash
$14.58M
Enterprise Value
$98.42M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
